15/10/02说明:此前论坛服务器频繁出错,现已更换服务器。今后论坛继续数据库备份,不备份上传附件。

肝胆相照论坛

 

 

肝胆相照论坛 论坛 学术讨论& HBV English 宿主DNA修复酶TDP2中形成的乙肝病毒共价闭合环状DNA的持 ...
查看: 1159|回复: 3
go

宿主DNA修复酶TDP2中形成的乙肝病毒共价闭合环状DNA的持久性 [复制链接]

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30441 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

1
发表于 2014-10-8 18:52 |只看该作者 |倒序浏览 |打印
Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses

    Christian Königer a,b,
    Ida Wingert a,
    Moritz Marsmann a,
    Christine Rösler a,
    Jürgen Beck a, 1, and
    Michael Nassa la,1

Author Affiliations

    aDepartment of Internal Medicine 2/Molecular Biology, University Hospital Freiburg, D-79106 Freiburg, Germany; and
    bFaculty of Biology, University of Freiburg, D-79104 Freiburg, Germany

    Edited by Francis V. Chisari, The Scripps Research Institute, La Jolla, CA, and approved July 28, 2014 (received for review May 29, 2014)



Significance

Chronic hepatitis B virus (HBV) infection puts >250 million humans at risk for developing liver cirrhosis and liver cancer. Current therapies are not curative because they do not target HBV´s persistence reservoir, the plasmid-like covalently closed circular DNA (cccDNA). RNA production from cccDNA initiates the generation of progeny virus via protein-primed reverse transcription, yielding viral polymerase-linked relaxed-circular DNA (RC-DNA). Its conversion, upon infection, into cccDNA requires multiple poorly understood steps, including polymerase removal. We found that the host enzyme tyrosyl-DNA-phosphodiesterase 2 (TDP2), important for repair of cellular protein–DNA adducts, performed this step in vitro and that TDP2 depletion impaired the conversion of RC-DNA to cccDNA in cells. These data establish a functional link between HBV and cellular DNA repair and pave the way for targeting HBV persistence.
Abstract

Hepatitis B virus (HBV), the causative agent of chronic hepatitis B and prototypic hepadnavirus, is a small DNA virus that replicates by protein-primed reverse transcription. The product is a 3-kb relaxed circular DNA (RC-DNA) in which one strand is linked to the viral polymerase (P protein) through a tyrosyl–DNA phosphodiester bond. Upon infection, the incoming RC-DNA is converted into covalently closed circular (ccc) DNA, which serves as a viral persistence reservoir that is refractory to current anti-HBV treatments. The mechanism of cccDNA formation is unknown, but the release of P protein is one mandatory step. Structural similarities between RC-DNA and cellular topoisomerase–DNA adducts and their known repair by tyrosyl-DNA-phosphodiesterase (TDP) 1 or TDP2 suggested that HBV may usurp these enzymes for its own purpose. Here we demonstrate that human and chicken TDP2, but only the yeast ortholog of TDP1, can specifically cleave the Tyr–DNA bond in virus-adapted model substrates and release P protein from authentic HBV and duck HBV (DHBV) RC-DNA in vitro, without prior proteolysis of the large P proteins. Consistent with TPD2’s having a physiological role in cccDNA formation, RNAi-mediated TDP2 depletion in human cells significantly slowed the conversion of RC-DNA to cccDNA. Ectopic TDP2 expression in the same cells restored faster conversion kinetics. These data strongly suggest that TDP2 is a first, although likely not the only, host DNA-repair factor involved in HBV cccDNA biogenesis. In addition to establishing a functional link between hepadnaviruses and DNA repair, our results open new prospects for directly targeting HBV persistence.

    1To whom correspondence may be addressed. Email: [email protected] or [email protected].

    Author contributions: C.K., J.B., and M.N. designed research; C.K., I.W., M.M., C.R., and J.B. performed research; C.K., M.M., J.B., and M.N. analyzed data; and C.K., J.B., and M.N. wrote the paper.

    The authors declare no conflict of interest.

    This article is a PNAS Direct Submission.

    This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10 ... 1/-/DCSupplemental.

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30441 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

2
发表于 2014-10-8 18:53 |只看该作者
宿主DNA修复酶TDP2中形成的乙肝病毒共价闭合环状DNA的持久性油藏的参与

    基督教KönigerA,B,
    伊达温格特A,
    莫里茨Marsmann A,
    恭罗斯勒A,
    于尔根贝克A,1,和
    迈克尔·纳萨啦,1

作者所属机构

    内科2/分子生物学,大学医院弗赖堡,D-79106的aDepartment德国弗赖堡;和
    弗莱堡大学bFaculty生物学,D-79104弗赖堡,德国

    弗朗西斯五Chisari,斯克里普斯研究所,拉霍亚加州编辑和批准2014年7月28日(收到审查2014年5月29日)



意义

慢性乙型肝炎病毒(HBV)感染看跌期权>2.5亿人在危险中为发展成为肝硬化和肝癌。目前的治疗是不能治愈,因为它们不针对HBV's持久储存器中,质粒等共价闭合环状DNA(cccDNA的)。从cccDNA的RNA生成启动子代病毒的产生通过蛋白质引发的逆转录,得到病毒聚合酶联宽松的环状DNA(RC-DNA)。它的转换,感染后,到cccDNA的需要多了解甚少的步骤,包括聚合酶清除。我们发现,该宿主酶的酪氨酰-DNA的磷酸二酯酶2(TDP2),用于修复细胞蛋白质-DNA加合物的重要,执行这个步骤在体外和TDP2耗尽受损的RC-DNA转化到cccDNA的细胞中。这些数据建立乙肝病毒和细胞DNA修复功能之间的联系和铺路针对乙肝病毒的持久性。
摘要

乙型肝炎病毒(HBV),慢性乙型肝炎和原型嗜肝DNA病毒的致病因子,是一种小的DNA病毒复制的蛋白质引发的反转录。该产品是通过酪氨酰-DNA的磷酸二酯键的3-kb的松弛环状DNA(RC-DNA),其中一条链是与病毒聚合酶(P蛋白)。在感染时,传入的RC-DNA被转化成共价闭合环状(CCC)的DNA,它作为病毒的持久性储存器是难治的电流抗HBV治疗。对cccDNA的形成机制还不清楚,但P蛋白的释放是必不可少的步骤。由酪氨酰-DNA的磷酸二酯酶(TDP)1 TDP2 RC-DNA和细胞拓扑异构酶-DNA加合物和他们已知的修复之间的结构相似性表明,乙肝病毒会侵占这些酶为自己的目的。在这里,我们表明,人类和鸡TDP2,但TDP1只有酵母的同源基因,能特异性切割的病毒适应模型基板的TYR-DNA的键,从正宗的乙肝和乙肝病毒的鸭子(乙型肝炎病毒)RC-DNA的体外释放P蛋白,没有大的P蛋白水解前。符合TPD2的具有cccDNA的形成的生理作用,在人体细胞中的RNAi介导的TDP2枯竭显著放缓的RC-DNA转化为cccDNA的。在同一个细胞中异位表达TDP2恢复更快的转换动力学。这些数据有力地表明,TDP2是第一,虽然可能不是唯一的,宿主DNA修复因子参与了HBV cccDNA的生物合成。除了建立嗜肝DNA病毒和DNA修复功能之间的联系,我们的研究结果开辟新的前景直接针对乙肝病毒的持久性。

    1要谁信件可能得到解决。电子邮件:[email protected][email protected]

    作者投稿:C.K.,J.B和M.N.设计研究; CK,IW的MM,华润,和JB进行研究; C.K.,M.M。,J.B和M.N.分析数据;和C.K.,J.B和M.N.写文章。

    作者宣称没有利益冲突。

    本文是美国国家科学院院刊直接提交。

    本文包含www.pnas.org/lookup/suppl/doi:10.1073/pnas.1409986111/-/DCSupplemental在线支持信息。

Rank: 10Rank: 10Rank: 10

现金
14949 元 
精华
帖子
8576 
注册时间
2008-4-12 
最后登录
2024-4-13 
3
发表于 2014-10-9 00:35 |只看该作者
这教授大牛啊
欢迎收看肝胆卫士大型生活服务类节目《乙肝勿扰》,我们的目标是:普度众友,收获幸福。
我是忠肝义胆MP4。忠肝义胆-战友的天地
QQ群搜"忠肝义胆孰能群"加入

Rank: 4

现金
108 元 
精华
帖子
81 
注册时间
2014-9-14 
最后登录
2016-8-26 
4
发表于 2014-10-9 09:54 |只看该作者
这是可以治愈的方向么?
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册

肝胆相照论坛

GMT+8, 2024-5-4 16:42 , Processed in 0.014607 second(s), 11 queries , Gzip On.

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.